Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
CLA3884 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A05321 | 33303564 | Gut | Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis. | 2020 | Details |
| A05324 | 33302643 | Ann Palliat Med | Computer-assisted ultrasound quantification analysis in fatty liver model of rats. | 2020 | Details |
| A05326 | 33302316 | Horm Metab Res | Acute Elevated Resistin Exacerbates Mitochondrial Damage and Aggravates Liver Steatosis Through AMPK/PGC-1α Signaling Pathway in Male NAFLD Mice. | 2020 | Details |
| A05345 | 33293347 | Diabetes Care | Hepatic Insulin Resistance Is Not Pathway Selective in Humans With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05356 | 33284184 | Am J Gastroenterol | Role of Noninvasive Tests in Clinical Gastroenterology Practices to Identify Patients With Nonalcoholic Steatohepatitis at High Risk of Adverse Outcomes: Expert Panel Recommendations. | 2021 | Details |
| A05372 | 33279947 | Eur J Clin Nutr | Lipid and saturated fatty acids intake and cardiovascular risk factors of obese children and adolescents. | 2020 | Details |
| A05386 | 33275161 | Diabetologia | The liver-alpha cell axis associates with liver fat and insulin resistance: a validation study in women with non-steatotic liver fat levels. | 2020 | Details |
| A05393 | 33272734 | Gastroenterol Hepatol | Silencing HIF-1α aggravates non-alcoholic fatty liver disease in vitro through inhibiting PPAR-α/ANGPTL4 singling pathway. | 2020 | Details |
| A05400 | 33270482 | Expert Rev Gastroenterol Hepatol | A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD. | 2020 | Details |
| A05405 | 33269229 | Quant Imaging Med Surg | Collagen deposition in the liver is strongly and positively associated with T1rho elongation while fat deposition is associated with T1rho shortening: an experimental study of methionine and choline-deficient (MCD) diet rat model. | 2020 | Details |
| A05421 | 33264665 | J Nutr Biochem | Hepatic metabolic adaptation and adipose tissue expansion are altered in mice with steatohepatitis induced by high-fat high sucrose diet. | 2020 | Details |
| A05423 | 33262120 | Diabetes | A High-Fat Diet Attenuates AMPK α1 in Adipocytes to Induce Exosome Shedding and Nonalcoholic Fatty Liver Development In Vivo. | 2020 | Details |
| A05430 | 33259845 | J Hepatol | Early changes in hepatic energy metabolism and lipid content in recent-onset type 1 and 2 diabetes mellitus. | 2020 | Details |
| A05433 | 33259137 | Liver Transpl | Histidine-Rich Glycoprotein Alleviates Liver Ischemia/Reperfusion Injury in Mice With Nonalcoholic Steatohepatitis. | 2021 | Details |
| A05450 | 33252713 | Protein Cell | Targeting the alternative bile acid synthetic pathway for metabolic diseases. | 2020 | Details |
| A05459 | 33249617 | J Clin Lab Anal | Ferritin as a key risk factor for nonalcoholic fatty liver disease in children with obesity. | 2020 | Details |
| A05464 | 33248170 | J Hepatol | Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores. | 2020 | Details |
| A05487 | 33236409 | Hepatology | Transient Versus Two-Dimensional Shear-Wave Elastography in a Multistep Strategy to Detect Advanced Fibrosis in NAFLD. | 2021 | Details |
| A05504 | 33227291 | Biochem Pharmacol | Aryl hydrocarbon receptor (AHR), integrating energy metabolism and microbial or obesity-mediated inflammation. | 2020 | Details |
| A05516 | 33220425 | Free Radic Biol Med | Physiological evidence of mitochondrial permeability transition pore opening caused by lipid deposition leading to hepatic steatosis in db/db mice. | 2020 | Details |
| A05520 | 33220154 | Liver Int | The NAFLD-MAFLD debate: Eminence vs evidence. | 2020 | Details |
| A05521 | 33220028 | Med Ultrason | Ultrasound-Guided Attenuation Parameter (UGAP) for the quantification of liver steatosis using the Controlled Attenuation Parameter (CAP) as the reference method. | 2020 | Details |
| A05523 | 33219609 | Liver Int | Serum aromatic and branched-chain amino acids associated with NASH demonstrate divergent associations with serum lipids. | 2020 | Details |
| A05529 | 33217835 | Medicine (Baltimore) | Effects of acupuncture for nonalcoholic fatty liver disease: A protocol for systematic review and meta-analysis. | 2020 | Details |
| A05536 | 33215899 | Transplantation | Live Confocal Imaging as a Novel Tool to Assess Liver Quality: Insights From a Murine Model. | 2020 | Details |
| A05540 | 33214329 | Pediatrics | Incidence of Nonalcoholic Fatty Liver Disease in Children: 2009-2018. | 2020 | Details |
| A05547 | 33212187 | Biochim Biophys Acta Mol Basis Dis | Vesicular ATP release from hepatocytes plays a role in the progression of nonalcoholic steatohepatitis. | 2020 | Details |
| A05573 | 33203174 | Nutrients | Nutraceutical Properties of Polyphenols against Liver Diseases. | 2020 | Details |
| A05579 | 33201570 | J Gastroenterol Hepatol | The association between non-alcoholic fatty liver disease (with or without metabolic syndrome) and extrahepatic cancer development. | 2020 | Details |
| A05626 | 33184849 | J Cell Physiol | Co-option of PPARα in the regulation of lipogenesis and fatty acid oxidation in CLA-induced hepatic steatosis. | 2020 | Details |
| A05627 | 33184021 | Nanomedicine | Formulation and intestinal absorption of naringenin loaded nanostructured lipid carrier and its inhibitory effects on nonalcoholic fatty liver disease. | 2020 | Details |
| A05633 | 33181119 | Lancet Gastroenterol Hepatol | Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa. | 2020 | Details |
| A05641 | 33178320 | Evid Based Complement Alternat Med | Sijunzi, Lizhong, and Fuzilizhong Decoction Alleviate Nonalcoholic Fatty Liver Disease through Activation of PPAR Pathway. | 2020 | Details |
| A05642 | 33177790 | World J Gastroenterol | Role of gut microbiota via the gut-liver-brain axis in digestive diseases. | 2020 | Details |
| A05651 | 33172809 | Dig Liver Dis | Leptin induces NAFLD progression through infiltrated CD8+ T lymphocytes mediating pyroptotic-like cell death of hepatocytes and macrophages. | 2020 | Details |
| A05666 | 33167328 | Int J Mol Sci | 9-PAHSA Prevents Mitochondrial Dysfunction and Increases the Viability of Steatotic Hepatocytes. | 2020 | Details |
| A05674 | 33164398 | Zhongguo Zhong Yao Za Zhi | [Mechanism of Alisma orientale in treating nonalcoholic fatty liver disease]. | 2020 | Details |
| A05690 | 33156104 | Am J Gastroenterol | Improving Outcomes of Bariatric Surgery in Patients With Cirrhosis in the United States: A Nationwide Assessment. | 2020 | Details |
| A05728 | 33142346 | Planta Med | Brown-Algae Polysaccharides as Active Constituents against Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A05737 | 33138044 | Cancers (Basel) | Non-Alcoholic Steatohepatitis as a Risk Factor for Intrahepatic Cholangiocarcinoma and Its Prognostic Role. | 2020 | Details |
| A05741 | 33136250 | J Med Ultrason (2001) | Histopathological findings of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2020 | Details |
| A05757 | 33131411 | Gut Microbes | Lactobacillus lactis CKDB001 ameliorate progression of nonalcoholic fatty liver disease through of gut microbiome: addendum. | 2020 | Details |
| A05764 | 33127939 | Sci Rep | Supplementation of branched-chain amino acids decreases fat accumulation in the liver through intestinal microbiota-mediated production of acetic acid. | 2020 | Details |
| A05778 | 33122322 | BMJ Open | Effects of sleep quality on non-alcoholic fatty liver disease: a cross-sectional survey. | 2020 | Details |
| A05789 | 33116724 | Diabetes Metab Syndr Obes | Association Between Subclinical Left Ventricular Myocardial Systolic Dysfunction Detected by Strain and Strain‑Rate Imaging and Liver Steatosis and Fibrosis Detected by Elastography and Controlled Attenuation Parameter in Patients with Metabolic Syndrome. | 2020 | Details |
| A05805 | 33113887 | Diagnostics (Basel) | Effect of Adult Weight Gain on Non-Alcoholic Fatty Liver Disease and Its Association with Anthropometric Parameters in the Lean Japanese Population. | 2020 | Details |
| A05812 | 33110165 | Sci Rep | Current NAFLD guidelines for risk stratification in diabetic patients have poor diagnostic discrimination. | 2020 | Details |
| A05819 | 33106416 | Proc Natl Acad Sci U S A | Stimulation of soluble guanylate cyclase exerts antiinflammatory actions in the liver through a VASP/NF-κB/NLRP3 inflammasome circuit. | 2020 | Details |
| A05820 | 33106141 | Curr Mol Med | Critical Role of NFκB in the Pathogenesis of Non-alcoholic Fatty Liver Disease: A Widespread Key Regulator. | 2021 | Details |
| A05847 | 33102495 | Front Med (Lausanne) | miRNA Dysregulation in the Development of Non-Alcoholic Fatty Liver Disease and the Related Disorders Type 2 Diabetes Mellitus and Cardiovascular Disease. | 2020 | Details |
| A05851 | 33101626 | Frontline Gastroenterol | Non-alcoholic fatty liver disease (NAFLD) in non-obese individuals. | 2019 | Details |
| A05854 | 33101202 | Front Endocrinol (Lausanne) | Dynamic Changes in Circulating Endocrine FGF19 Subfamily and Fetuin-A in Response to Intralipid and Insulin Infusions in Healthy and PCOS Women. | 2020 | Details |
| A05894 | 33084982 | Acta Diabetol | Association of 1-deoxy-sphingolipids with steatosis but not steatohepatitis nor fibrosis in non-alcoholic fatty liver disease. | 2020 | Details |
| A05930 | 33072533 | Adv Pharm Bull | The Evaluation of Effective Drugs for the Treatment of Non-Alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis. | 2020 | Details |
| A05940 | 33069975 | Comput Methods Programs Biomed | Combined methods of optical spectroscopy and artificial intelligence in the assessment of experimentally induced non-alcoholic fatty liver. | 2020 | Details |
| A05942 | 33068638 | J Hepatol | Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis. | 2020 | Details |
| A05948 | 33066325 | Cancers (Basel) | Chemerin Is Induced in Non-Alcoholic Fatty Liver Disease and Hepatitis B-Related Hepatocellular Carcinoma. | 2020 | Details |
| A05953 | 33064150 | J Clin Endocrinol Metab | The PNPLA3-I148M Variant Confers an Antiatherogenic Lipid Profile in Insulin-resistant Patients. | 2021 | Details |
| A05954 | 33063664 | Elife | Weight loss, insulin resistance, and study design confound results in a meta-analysis of animal models of fatty liver. | 2020 | Details |
| A05978 | 33053941 | Clin Mol Hepatol | Long non-coding RNAs in liver diseases: Focusing on nonalcoholic fatty liver disease, alcohol-related liver disease, and cholestatic liver disease. | 2020 | Details |
| A05987 | 33050138 | Biomedicines | Tissue-Specific Role of Macrophages in Noninfectious Inflammatory Disorders. | 2020 | Details |
| A05997 | 33045675 | J Trace Elem Med Biol | A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial. | 2020 | Details |
| A05999 | 33045214 | Life Sci | Evolutionary conservation of long non-coding RNAs in non-alcoholic fatty liver disease. | 2020 | Details |
| A06005 | 33039693 | Contemp Clin Trials | Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers. | 2020 | Details |
| A06030 | 33034193 | J Agric Food Chem | High-Fat Proteins Drive Dynamic Changes in Gut Microbiota, Hepatic Metabolome, and Endotoxemia-TLR-4-NFκB-Mediated Inflammation in Mice. | 2020 | Details |
| A06038 | 33032263 | J Endocrinol | Lactobacillus pentosus strain S-PT84 improves steatohepatitis by maintaining gut permeability. | 2020 | Details |
| A06069 | 33020474 | Nat Commun | Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD. | 2020 | Details |
| A06073 | 33016540 | Aliment Pharmacol Ther | Patterns and predictors of mortality and disease progression among patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A06094 | 33010062 | Biotechnol Appl Biochem | Circulating mRNA and plasma levels of osteoprotegerin and receptor activator of NF-κB ligand in nonalcoholic fatty liver disease. | 2020 | Details |
| A06096 | 33009010 | AIDS | Liver steatosis and nonalcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV. | 2020 | Details |
| A06116 | 32999906 | GE Port J Gastroenterol | Gastrointestinal Microbiome - What We Need to Know in Clinical Practice. | 2020 | Details |
| A06119 | 32998280 | Metabolites | Neuronal Lipoprotein Lipase Deficiency Alters Neuronal Function and Hepatic Metabolism. | 2020 | Details |
| A06123 | 32997882 | Liver Int | MAFLD identifies patients with significant hepatic fibrosis better than NAFLD. | 2020 | Details |
| A06162 | 32982112 | World J Gastroenterol | Arachidyl amido cholanoic acid improves liver glucose and lipid homeostasis in nonalcoholic steatohepatitis via AMPK and mTOR regulation. | 2020 | Details |
| A06164 | 32981386 | Expert Rev Clin Pharmacol | The pharmacological treatment of nonalcoholic fatty liver disease in children. | 2020 | Details |
| A06166 | 32981113 | Aliment Pharmacol Ther | Digital pathology: accurate technique for quantitative assessment of histological features in metabolic-associated fatty liver disease. | 2020 | Details |
| A06169 | 32980849 | Cerebrovasc Dis | Advanced Liver Fibrosis Predicts Unfavorable Long-Term Prognosis in First-Ever Ischemic Stroke or Transient Ischemic Attack. | 2020 | Details |
| A06172 | 32979184 | Obes Surg | Prevalence and Factors Associated with Hepatic Iron Overload in Obese Individuals Undergoing Bariatric Surgery: a Cross-Sectional Study. | 2020 | Details |
| A06193 | 32975050 | J Dig Dis | Non-alcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease: Conceptual changes for clinicians, researchers and patients. | 2020 | Details |
| A06205 | 32968123 | Sci Rep | Automated thermal imaging for the detection of fatty liver disease. | 2020 | Details |
| A06247 | 32952872 | World J Hepatol | Lipidomics in non-alcoholic fatty liver disease. | 2020 | Details |
| A06260 | 32949785 | Ann Hepatol | Usefulness of collagen type IV in the detection of significant liver fibrosis in nonalcoholic fatty liver disease. | 2020 | Details |
| A06266 | 32947564 | J Pediatr Gastroenterol Nutr | Lipidomics in Nonalcoholic Fatty Liver Disease: Exploring Serum Lipids as Biomarkers for Pediatric Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06273 | 32945305 | Food Funct | Lactobacillus fermentum CQPC06 in naturally fermented pickles prevents non-alcoholic fatty liver disease by stabilizing the gut-liver axis in mice. | 2020 | Details |
| A06274 | 32945071 | Diabetes Obes Metab | A look to the future in non-alcoholic fatty liver disease: Are glucagon-like peptide-1 analogues or sodium-glucose co-transporter-2 inhibitors the answer? | 2020 | Details |
| A06283 | 32942773 | Molecules | New Perspectives of S-Adenosylmethionine (SAMe) Applications to Attenuate Fatty Acid-Induced Steatosis and Oxidative Stress in Hepatic and Endothelial Cells. | 2020 | Details |
| A06294 | 32938556 | Obes Res Clin Pract | Effects of obesity reduction on transient elastography-based parameters in pediatric non-alcoholic fatty liver disease. | 2020 | Details |
| A06300 | 32936098 | J R Coll Physicians Edinb | Diagnosis and management of fatty liver. | 2020 | Details |
| A06305 | 32934691 | Exp Ther Med | Abnormal metabolic processes involved in the pathogenesis of non-alcoholic fatty liver disease (Review). | 2020 | Details |
| A06319 | 32930860 | Wien Klin Wochenschr | Open-label phase II study evaluating safety and efficacy of the non-steroidal farnesoid X receptor agonist PX-104 in non-alcoholic fatty liver disease. | 2020 | Details |
| A06336 | 32924000 | Metabol Open | The incidence of COVID-19 in patients with metabolic syndrome and non-alcoholic steatohepatitis: A population-based study. | 2020 | Details |
| A06342 | 32922442 | Front Genet | Does Cannabis Intake Protect Against Non-alcoholic Fatty Liver Disease? A Two-Sample Mendelian Randomization Study. | 2020 | Details |
| A06347 | 32920973 | Mol Nutr Food Res | Dietary Rapeseed Oil Supplementation Reduces Hepatic Steatosis in Obese Men-A Randomized Controlled Trial. | 2020 | Details |
| A06352 | 32919135 | Bioorg Chem | Design, synthesis and structure-activity relationship studies of novel partial FXR agonists for the treatment of fatty liver. | 2020 | Details |
| A06353 | 32919087 | Ann Hepatol | Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population. | 2020 | Details |
| A06368 | 32910776 | Diabetes Care | Role of Patatin-Like Phospholipase Domain-Containing 3 Gene for Hepatic Lipid Content and Insulin Resistance in Diabetes. | 2020 | Details |
| A06369 | 32910646 | J Med Chem | Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of Fructose. | 2020 | Details |
| A06376 | 32907986 | J Lipid Res | Membrane-bound sn-1,2-diacylglycerols explain the dissociation of hepatic insulin resistance from hepatic steatosis in MTTP knockout mice. | 2020 | Details |
| A06389 | 32898995 | Medicine (Baltimore) | Validating candidate biomarkers for different stages of non-alcoholic fatty liver disease. | 2020 | Details |
| A06400 | 32892668 | Expert Rev Gastroenterol Hepatol | Non-alcoholic fatty liver disease: molecular and cellular interplays of the lipid metabolism in a steatotic liver. | 2020 | Details |